Princeton Drug Discovery, Inc
Princeton Drug Discovery, Inc. is a biotechnology company based in Monmouth Junction, NJ, focused on developing innovative therapies for autoimmune diseases, particularly multiple sclerosis (MS). They are pioneering the concept of MHC inhibition to create drugs that target genetically associated conditions, with a lead candidate, PV3212, demonstrating high potency and specificity in treating MS without compromising normal immune responses.
The company employs expert medicinal chemistry and therapeutic expertise to support drug discovery services, actively engaging in research and development to address various autoimmune disease targets. Their approach includes developing novel small molecule antagonists, with a commitment to advancing therapeutic strategies that offer significant improvements over existing treatments.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.
